MedTrace Logo

Muscular Biomarkers in Amyotrophic Lateral Sclerosis

NCT02670226 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2025-12-22

No results posted yet for this study

Summary

The first objective is to find some biomarkers, or a profile of biomarkers of ALS to help to diagnosis. The second objective is to better understand the pathogenesis of this disease by the exploration of muscle, blood and satellite cells metabolomes and transcriptomes.

Conditions

Interventions

OTHER

Samples

Blood samples, muscle biopsy

Sponsors & Collaborators

  • University Hospital, Tours

    lead OTHER

Principal Investigators

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-03-29
Primary Completion
2019-10-15
Completion
2019-12-09

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02670226 on ClinicalTrials.gov